SuppreMol launched as a new company
Advertisement
Z-Cube, the corporate venture capital arm of the Zambon Group took another important step forwards in fostering pharmaceutical innovation, signing a contract to provide finance and expert support to SuppreMol GmbH. This marked the project's official launch as a new company after several years of basic research and proof of principle of a new therapeutic approach in autoimmune diseases. SuppreMol is a spin-off company of the Max-Planck-Institute of biochemistry in Munich, Germany set up with the support of Garching Innovation GmbH, the technology transfer office of the Max Planck Society.
SuppreMol is working on the development of drugs for the treatment of autoimmune diseases and allergies through innovative therapeutic approaches centred on Fc -receptors. The development of these drugs is based on patent rights owned by the Max-Planck-Society and licensed to SuppreMol by the Society's Technology Transfer office, Garching Innovation. SuppreMol's principal objective is to prove the therapeutic efficacy of a soluble Fc receptor in the treatment of Idiopathic Thrombocytopenic Purpura, Systemic Lupus Erythematosus, Rheumatoid Arthritis and other autoimmune diseases.
Most read news
Topics
Organizations
Other news from the department business & finance
These products might interest you
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
New compounding line for Altuglas International at its Bristol facility (Pennsylvania)
ACCELRYS ANNOUNCES TOPKAT UPDATE FOR HIGH THROUGHPUT TOXICITY PROFILING
A plastic that remembers - Bayer MaterialScience and BAM Federal Institute for Materials Research and Testing develop shape memory polymer from thermoplastic polyurethane
Thermo Fisher (Kandel) GmbH - Kandel, Germany
New Partner for InProcess Instruments in Great Britain and Ireland
Air Products Brings Hydrogen Production Facility On-Stream to Supply ExxonMobil's Joliet, Illinois Refinery
Echinopsis_lageniformis
'Hot' oxygen atoms on titanium dioxide motivated by more than just temperature - PNNL scientists find unexpected chemical behavior on catalyst surface
InProcess Instruments GmbH - Bremen, Germany
Beiersdorf: Focus in America pays off - tesa records sales growth of 15.6%
When Electrons "Jump" into Water: The Secret Behind High Electrode Capacities - Researchers decode how minimal "electron spillover" increases energy storage capacity tenfold